Cargando…
Two Distinct Pathways Mediated by PA28 and hsp90 in Major Histocompatibility Complex Class I Antigen Processing
Major histocompatibility complex (MHC) class I ligands are mainly produced by the proteasome. Herein, we show that the processing of antigens is regulated by two distinct pathways, one requiring PA28 and the other hsp90. Both hsp90 and PA28 enhanced the antigen processing of ovalbumin (OVA). Geldana...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193925/ https://www.ncbi.nlm.nih.gov/pubmed/12119343 http://dx.doi.org/10.1084/jem.20011922 |
_version_ | 1782147584633077760 |
---|---|
author | Yamano, Taketoshi Murata, Shigeo Shimbara, Naoki Tanaka, Noriaki Chiba, Tomoki Tanaka, Keiji Yui, Katsuyuki Udono, Heiichiro |
author_facet | Yamano, Taketoshi Murata, Shigeo Shimbara, Naoki Tanaka, Noriaki Chiba, Tomoki Tanaka, Keiji Yui, Katsuyuki Udono, Heiichiro |
author_sort | Yamano, Taketoshi |
collection | PubMed |
description | Major histocompatibility complex (MHC) class I ligands are mainly produced by the proteasome. Herein, we show that the processing of antigens is regulated by two distinct pathways, one requiring PA28 and the other hsp90. Both hsp90 and PA28 enhanced the antigen processing of ovalbumin (OVA). Geldanamycin, an inhibitor of hsp90, almost completely suppressed OVA antigen presentation in PA28α(−/−)/β(−/−) lipopolysaccharide blasts, but not in wild-type cells, indicating that hsp90 compensates for the loss of PA28 and is essential in the PA28-independent pathway. In contrast, treatment of cells with interferon (IFN)-γ, which induces PA28 expression, abrogated the requirement of hsp90, suggesting that IFN-γ enhances the PA28-dependent pathway, whereas it diminishes hsp90-dependent pathway. Importantly, IFN-γ did not induce MHC class I expressions in PA28-deficient cells, indicating a prominent role for PA28 in IFN-γ–stimulated peptide supply. Thus, these two pathways operate either redundantly or specifically, depending on antigen species and cell type. |
format | Text |
id | pubmed-2193925 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2002 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-21939252008-04-11 Two Distinct Pathways Mediated by PA28 and hsp90 in Major Histocompatibility Complex Class I Antigen Processing Yamano, Taketoshi Murata, Shigeo Shimbara, Naoki Tanaka, Noriaki Chiba, Tomoki Tanaka, Keiji Yui, Katsuyuki Udono, Heiichiro J Exp Med Article Major histocompatibility complex (MHC) class I ligands are mainly produced by the proteasome. Herein, we show that the processing of antigens is regulated by two distinct pathways, one requiring PA28 and the other hsp90. Both hsp90 and PA28 enhanced the antigen processing of ovalbumin (OVA). Geldanamycin, an inhibitor of hsp90, almost completely suppressed OVA antigen presentation in PA28α(−/−)/β(−/−) lipopolysaccharide blasts, but not in wild-type cells, indicating that hsp90 compensates for the loss of PA28 and is essential in the PA28-independent pathway. In contrast, treatment of cells with interferon (IFN)-γ, which induces PA28 expression, abrogated the requirement of hsp90, suggesting that IFN-γ enhances the PA28-dependent pathway, whereas it diminishes hsp90-dependent pathway. Importantly, IFN-γ did not induce MHC class I expressions in PA28-deficient cells, indicating a prominent role for PA28 in IFN-γ–stimulated peptide supply. Thus, these two pathways operate either redundantly or specifically, depending on antigen species and cell type. The Rockefeller University Press 2002-07-15 /pmc/articles/PMC2193925/ /pubmed/12119343 http://dx.doi.org/10.1084/jem.20011922 Text en Copyright © 2002, The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Article Yamano, Taketoshi Murata, Shigeo Shimbara, Naoki Tanaka, Noriaki Chiba, Tomoki Tanaka, Keiji Yui, Katsuyuki Udono, Heiichiro Two Distinct Pathways Mediated by PA28 and hsp90 in Major Histocompatibility Complex Class I Antigen Processing |
title | Two Distinct Pathways Mediated by PA28 and hsp90 in Major Histocompatibility Complex Class I Antigen Processing |
title_full | Two Distinct Pathways Mediated by PA28 and hsp90 in Major Histocompatibility Complex Class I Antigen Processing |
title_fullStr | Two Distinct Pathways Mediated by PA28 and hsp90 in Major Histocompatibility Complex Class I Antigen Processing |
title_full_unstemmed | Two Distinct Pathways Mediated by PA28 and hsp90 in Major Histocompatibility Complex Class I Antigen Processing |
title_short | Two Distinct Pathways Mediated by PA28 and hsp90 in Major Histocompatibility Complex Class I Antigen Processing |
title_sort | two distinct pathways mediated by pa28 and hsp90 in major histocompatibility complex class i antigen processing |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193925/ https://www.ncbi.nlm.nih.gov/pubmed/12119343 http://dx.doi.org/10.1084/jem.20011922 |
work_keys_str_mv | AT yamanotaketoshi twodistinctpathwaysmediatedbypa28andhsp90inmajorhistocompatibilitycomplexclassiantigenprocessing AT muratashigeo twodistinctpathwaysmediatedbypa28andhsp90inmajorhistocompatibilitycomplexclassiantigenprocessing AT shimbaranaoki twodistinctpathwaysmediatedbypa28andhsp90inmajorhistocompatibilitycomplexclassiantigenprocessing AT tanakanoriaki twodistinctpathwaysmediatedbypa28andhsp90inmajorhistocompatibilitycomplexclassiantigenprocessing AT chibatomoki twodistinctpathwaysmediatedbypa28andhsp90inmajorhistocompatibilitycomplexclassiantigenprocessing AT tanakakeiji twodistinctpathwaysmediatedbypa28andhsp90inmajorhistocompatibilitycomplexclassiantigenprocessing AT yuikatsuyuki twodistinctpathwaysmediatedbypa28andhsp90inmajorhistocompatibilitycomplexclassiantigenprocessing AT udonoheiichiro twodistinctpathwaysmediatedbypa28andhsp90inmajorhistocompatibilitycomplexclassiantigenprocessing |